During the past decade, Oklahoma Medical Research Foundation; MS Center of Excellence conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oklahoma Medical Research Foundation; MS Center of Excellence" #1 sponsor was "Genentech, Inc." with 3 trials, followed by "Genzyme, a Sanofi Company" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Acorda Therapeutics" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oklahoma Medical Research Foundation; MS Center of Excellence" #1 collaborator was "Bayer" with 3 trials as a collaborator, "BCS Consulting, Inc." with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Prometrika, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Oklahoma Medical Research Foundation; MS Center of Excellence" are "Multiple Sclerosis" (8 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Multiple Sclerosis (MS)" (1 trials) and "Relapsing Multiple Sclerorsis" (1 trials). Many other conditions were trialed in "Oklahoma Medical Research Foundation; MS Center of Excellence" in a lesser frequency.

Most popular intervention types in "Oklahoma Medical Research Foundation; MS Center of Excellence" are "Drug" (11 trials), "Other" (4 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ocrelizumab" (4 trials), "Antihistamine" (2 trials), "Interferon beta-1a" (2 trials) and "Alemtuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oklahoma Medical Research Foundation; MS Center of Excellence" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Oklahoma Medical Research Foundation; MS Center of Excellence". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Oklahoma Medical Research Foundation; MS Center of Excellence, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oklahoma Medical Research Foundation; MS Center of Excellence, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".